Douglas Lamont

473 total citations
7 papers, 353 citations indexed

About

Douglas Lamont is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Douglas Lamont has authored 7 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Epidemiology and 2 papers in Surgery. Recurrent topics in Douglas Lamont's work include Advanced Proteomics Techniques and Applications (2 papers), Metabolism, Diabetes, and Cancer (2 papers) and Trypanosoma species research and implications (1 paper). Douglas Lamont is often cited by papers focused on Advanced Proteomics Techniques and Applications (2 papers), Metabolism, Diabetes, and Cancer (2 papers) and Trypanosoma species research and implications (1 paper). Douglas Lamont collaborates with scholars based in United Kingdom, France and Sweden. Douglas Lamont's co-authors include François‐Michel Boisvert, Marek Gierliński, Geoffrey J. Barton, Fabien Charrière, Angus I. Lamond, Yasmeen Ahmad, Michelle S. Scott, Neus Visa, Piergiorgio Percipalle and Anne von Euler and has published in prestigious journals such as The FASEB Journal, PLoS Genetics and Molecular & Cellular Proteomics.

In The Last Decade

Douglas Lamont

7 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglas Lamont United Kingdom	5	283	102	53	36	30	7	353
Debbie L. Cunningham United Kingdom	12	328 1.2×	207 2.0×	85 1.6×	47 1.3×	38 1.3×	17	480
Federico Uliana Switzerland	11	212 0.7×	65 0.6×	68 1.3×	35 1.0×	12 0.4×	22	302
Askar A. Kleefeldt United Kingdom	3	281 1.0×	100 1.0×	33 0.6×	28 0.8×	10 0.3×	4	335
Barbara Kaboord United States	8	206 0.7×	70 0.7×	40 0.8×	45 1.3×	11 0.4×	11	308
Benjamin D. Stein United States	8	296 1.0×	111 1.1×	39 0.7×	53 1.5×	31 1.0×	10	421
Lars Nilse Germany	5	197 0.7×	143 1.4×	32 0.6×	42 1.2×	16 0.5×	6	284
Annie Ha Canada	4	352 1.2×	251 2.5×	30 0.6×	35 1.0×	19 0.6×	9	505
Valentine Rech de Laval Switzerland	6	297 1.0×	93 0.9×	14 0.3×	26 0.7×	24 0.8×	8	364
Kira Cozzolino United States	7	329 1.2×	39 0.4×	30 0.6×	28 0.8×	23 0.8×	10	429
Maja Gehre Germany	6	416 1.5×	100 1.0×	37 0.7×	29 0.8×	9 0.3×	7	473

Countries citing papers authored by Douglas Lamont

Since Specialization

Citations

This map shows the geographic impact of Douglas Lamont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Lamont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Lamont more than expected).

Fields of papers citing papers by Douglas Lamont

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Lamont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Lamont. The network helps show where Douglas Lamont may publish in the future.

Co-authorship network of co-authors of Douglas Lamont

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Lamont. A scholar is included among the top collaborators of Douglas Lamont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Lamont. Douglas Lamont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

McNeilly, Alison D., et al.. (2025). In-depth proteomic profiling identifies potentiation of the LPS response by 7-ketocholesterol. PubMed. 11. 100285–100285. 1 indexed citations

2.

Forteath, Calum, Ify Mordi, Amy Cameron, et al.. (2023). Amino acid homeostasis is a target of metformin therapy. Molecular Metabolism. 74. 101750–101750. 5 indexed citations

3.

Howden, Andrew J.M., et al.. (2022). AMPK integrates metabolite and kinase-based immunometabolic control in macrophages. Molecular Metabolism. 68. 101661–101661. 16 indexed citations

4.

Vadgama, Nirmal, Douglas Lamont, John Hardy, Jamal Nasir, & Ruth C. Lovering. (2019). Distinct proteomic profiles in monozygotic twins discordant for ischaemic stroke. Molecular and Cellular Biochemistry. 456(1-2). 157–165. 7 indexed citations

5.

Sarshad, Aishe A., Martin Corcoran, Bader Almuzzaini, et al.. (2014). Glycogen Synthase Kinase (GSK) 3β Phosphorylates and Protects Nuclear Myosin 1c from Proteasome-Mediated Degradation to Activate rDNA Transcription in Early G1 Cells. PLoS Genetics. 10(6). e1004390–e1004390. 24 indexed citations

6.

Boisvert, François‐Michel, Yasmeen Ahmad, Marek Gierliński, et al.. (2011). A Quantitative Spatial Proteomics Analysis of Proteome Turnover in Human Cells. Molecular & Cellular Proteomics. 11(3). M111.011429–M111.011429. 299 indexed citations

7.

Nakayasu, Ernesto, Ana Cláudia Torrecilhas, Fábio C. Gozzo, et al.. (2006). The proteome of Trypanosoma cruzi shed vesicles involved in host immunomodulation and cell invasion. The FASEB Journal. 20(4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact